Note · Sep 2026
Not everything needs a patent: patent strategy should follow business strategy
A patent is an exclusionary right, not permission to build. The better question is not "can we patent this?" but "what would having this patent actually accomplish for the business?"
There is a common assumption in technology commercialization: if something is innovative, we should patent it. Sometimes that is exactly the right strategy. Sometimes it is not.
The more important question is not simply "can we patent this?" It is "what would having this patent actually accomplish for the business?" That distinction becomes especially important for software companies, startups, and companies operating in fast-moving technology sectors where the product may change considerably before a patent ever issues. A patent can be a powerful asset. But it is important to understand what a patent actually provides before deciding how much time, money, and attention to invest in obtaining one.
A patent does not give you permission to build something
Perhaps the most important misconception about patents is the idea that receiving a patent means you now have the legal right to make or sell the patented technology. That is not what a patent does. A patent is fundamentally an exclusionary right.
In the United States, a patent generally gives its owner the ability to exclude others from making, using, selling, offering for sale, or importing what is covered by the patent claims. The claims define the boundaries of that exclusionary right. But the patent does not automatically give the patent owner freedom to practice the invention. Those are two separate questions:
| Question | What it means |
|---|---|
| Can I patent this? | Does my invention satisfy the legal requirements for patent protection? |
| Can I commercialize this without infringing someone else? | Does making, using, or selling my product fall within the claims of another party's enforceable patent? |
Figure 1 · Two separate gates
Patentability
Can I obtain claims covering my invention?
- Novelty
- Non-obviousness
- Eligible subject matter
- Adequate disclosure
Freedom to operate
Can I commercialize without infringing someone else's claims?
- Competitor patents
- Existing platform patents
- Component patents
- Licensing requirements
- Design-around possibilities
Passing the patentability gate does not automatically mean passing the freedom-to-operate gate.
You can own a patent and still infringe someone else's patent
This sounds counterintuitive until you think about how technologies evolve. Most inventions are improvements on technologies that already exist.
Imagine, for example, that someone owns a broad patent covering a particular mechanical pencil architecture. Later, you invent a completely new eraser mechanism for that pencil. Your eraser mechanism may be novel enough to receive its own patent. You may therefore own a patent covering "a retractable eraser assembly having features X, Y, and Z."
But if you manufacture the entire pencil and the underlying pencil architecture is still covered by somebody else's enforceable patent, your eraser patent does not magically give you permission to manufacture the pencil. You might have the right to prevent others from copying your improved eraser. At the same time, the earlier patent owner might have the right to prevent you from producing the pencil containing it. Both patents can exist simultaneously. This is sometimes described as a blocking patent situation.
Figure 2 · The blocking patent
Patent A
Core pencil architecture
Patent B
Improved retractable eraser
Patent B may be patentable because it is an improvement. But practicing Patent B may still require practicing technology covered by Patent A.
Neither patent automatically gives complete freedom to operate
This happens in real technologies all the time
The pencil example may sound simplistic, but the principle applies across sophisticated industries. Consider several examples.
| Technology | Your potential patent | Earlier rights that could still matter |
|---|---|---|
| Software | A new machine-learning optimization method | Patented compression, communications, database, or hardware methods implemented by the system |
| Medical device | A new sensor arrangement | Patents covering the underlying catheter, pump, imaging system, or delivery platform |
| Battery technology | A new thermal-management configuration | Patents covering portions of the cell architecture, battery-management system, or manufacturing process |
| Semiconductor | A new circuit architecture | Patents covering fabrication processes, memory structures, interfaces, or other incorporated components |
| Biotechnology | A new engineered biological pathway | Patents covering the host organism, expression system, vectors, enzymes, or other underlying tools |
| Manufacturing | A new additive-manufacturing control method | Patents covering printing mechanisms, material-delivery systems, or process steps |
| Communications | A new improvement to wireless transmission | Standard-essential patents or other patents covering foundational communications technologies |
Take a software example. Suppose your company patents a new method for optimizing image transmission based on network conditions. You may have a perfectly legitimate patent on your optimization method. But your software could still use a patented video codec, communications protocol implementation, or other protected technology. Your patent protects your improvement. It does not immunize the rest of your product from somebody else's intellectual-property rights.
Patentability is not freedom to operate
This distinction deserves its own terminology because it represents two completely different forms of analysis. Patentability analysis asks whether you may be able to obtain patent protection for your invention. A freedom-to-operate analysis, sometimes called an FTO analysis, investigates whether commercialization of a product or process may implicate patent rights held by others.
Figure 3 · Two directions of analysis
Your technology
Two different questions · two different analyses · two different business risks
So why patent anything?
None of this means patents are unimportant. Quite the opposite. Patents can be extraordinarily powerful when they protect technology that matters commercially. But patents should be treated as strategic business assets rather than trophies awarded for technical creativity.
The decision to patent should begin with a simple question: what are we trying to accomplish? There are many legitimate answers. A company may want to:
- prevent competitors from copying an important technical architecture;
- strengthen its negotiating position in licensing discussions;
- establish proprietary rights around a core platform;
- create assets that could become valuable during acquisition;
- support partnerships or joint ventures;
- protect R&D investments that would otherwise be relatively easy to replicate;
- demonstrate technological differentiation to investors; or
- create strategic uncertainty for competitors.
Those are business reasons for obtaining patents. And sometimes those reasons are more important than the possibility of ever filing a patent infringement lawsuit.
Software makes the patent decision particularly interesting
Software companies present an especially interesting case. Software is not categorically unpatentable. Certain computer-implemented methods, systems, architectures, control processes, data-processing techniques, and other technical implementations may potentially qualify for patent protection.
But software also presents unique challenges. Software changes quickly. Architectures evolve. Products pivot. Competitors may implement the same commercial concept through very different technical approaches. And some software-related inventions encounter complicated patent-eligibility questions, particularly when claims begin to resemble abstract ideas, mathematical relationships, generalized business processes, or generic use of computers.
That means software companies should be especially disciplined when asking: is this invention important enough to justify patent protection?
The opportunity cost of patenting
Every patent strategy has an opportunity cost. Preparing a quality patent application requires technical analysis, inventor time, attorney or patent-agent time, drafting, prosecution, responses to the patent office, and eventually maintenance expenses. International protection can multiply those costs substantially.
Those resources could alternatively be spent on product development, hiring, customer acquisition, cybersecurity, proprietary datasets, infrastructure, integrations, regulatory work, trade-secret controls, faster commercialization, or another invention that may be significantly more strategically important.
That does not make patent spending wasteful. It means patent spending should compete against other uses of capital just like every other business investment.
Figure 4 · The IP investment decision
Patent
- Exclusionary rights
- Licensing leverage
- Investor signaling
- Competitive deterrence
- Acquisition value
Alternative investments
- Product development
- Trade secrets
- Data
- Brand
- Customer acquisition
- Speed
- Infrastructure
Why companies patent even when they may never sue anyone
Two reasons deserve particular attention.
1. Investor signaling
Patents can communicate something important to investors. Sophisticated investors understand that patents vary dramatically in quality. One broad and commercially meaningful patent may be more valuable than dozens of narrow patents covering peripheral features. Nevertheless, patents can provide evidence that a company has developed proprietary technology, considered ownership of that technology, invested in protecting important innovations, and created assets that could survive beyond the people who originally developed them.
This can be particularly important in deep technology. A company may have spent years developing a novel manufacturing process, biotechnology platform, materials system, semiconductor architecture, or computational method. Without intellectual-property protection, much of that investment exists primarily as institutional knowledge. Patents can convert portions of that technical development into identifiable legal assets. That can become meaningful during fundraising, due diligence, licensing, partnerships, acquisitions, and valuation discussions.
But investor signaling should not become patent theater. A portfolio containing many patents that do not meaningfully protect the company's business is not necessarily more valuable than a carefully constructed portfolio containing a few strategically important patents.
2. Competitive deterrence
The second reason is more subtle: deterrence. A patent does not have to appear in a courtroom to influence competitor behavior. Imagine entering a market and discovering that your competitor has no apparent patent position. Your technical team may study the product and determine how closely it can reproduce particular functionality. Now imagine discovering instead that the company has several issued patents, pending applications, continuation applications, and patents covering multiple implementations of the underlying technology.
The calculation changes. Your attorneys and technical teams may now need to determine:
- What exactly do the claims cover?
- Are we inside those claims?
- Can we design around them?
- What might the pending applications eventually cover?
- Is licensing necessary?
- Could this technology create problems during future financing?
- Would an acquirer care about this risk?
- Should we simply implement the product differently?
The competitor may ultimately determine that there is no infringement. But the existence of the portfolio has already affected behavior. It has increased the cost of evaluating entry into the space. It has introduced uncertainty. And uncertainty can itself create strategic value.
Patents can create negotiating leverage
Overlapping patent rights can also create negotiation. Return to our earlier example. Company A owns a patent covering a foundational technology. Company B later develops and patents an important improvement. Company A may want the improvement. Company B may need access to the foundational technology. Neither company necessarily has complete freedom to proceed independently. That creates the possibility of licensing, cross-licensing, partnerships, acquisitions, joint ventures, or other commercial arrangements.
Figure 5 · Patent leverage
Foundational
patent
Improvement
patent
Commercial
negotiation
A patent is not the same thing as a moat
Another mistake is treating the number of patents a company owns as a proxy for competitive strength. It is not. A company with twenty patents may have a weaker competitive position than a company with two. A company with no patents may still have an extraordinary business moat.
Consider what competitors might actually have to reproduce:
| Competitive advantage | Patent necessary? |
|---|---|
| Proprietary dataset accumulated over ten years | Possibly not |
| Deep customer integrations | Usually not |
| Network effects | Usually not |
| Brand recognition | No |
| Trade-secret manufacturing process | Potentially better kept secret |
| Exceptional execution speed | No |
| Regulatory approvals and know-how | Not necessarily |
| Proprietary algorithm | Depends on implementation and strategy |
| Novel physical architecture easily reverse engineered | Patent protection may be highly valuable |
| Platform technology required throughout an industry | Patent protection may be extremely valuable |
The strongest companies often combine multiple forms of protection. Their moat may include patents plus trade secrets, data, know-how, brand, customer relationships, execution, and regulatory positioning. A patent portfolio should therefore be understood as one component of competitive strategy, not competitive strategy itself.
The better question: what happens if we do not patent it?
When evaluating an invention, one of the most useful questions may be: what happens if we do not file a patent application?
Suppose a competitor discovers the technology tomorrow. Could they easily reproduce it? Could they determine how it works from the product? Would they need years of experimental data to reproduce the result? Would they independently develop the same approach? Could the company reasonably maintain the technology as a trade secret? Would publication establish useful defensive prior art? Would being first to market matter more than having a twenty-year patent term? Would investors expect intellectual-property protection? Would an acquirer expect it? Would licensing become an important business model?
Those questions reveal whether the invention actually deserves patent investment.
A simple patent strategy framework
Before filing, companies can ask five questions.
| Question | Strategic purpose |
|---|---|
| 1. Is the technology commercially important? | Avoid patenting features that do not meaningfully contribute to competitive advantage. |
| 2. Can competitors easily reproduce it? | Reverse-engineerable technologies may benefit more from patents than hidden processes. |
| 3. Could competitors design around the claims easily? | Patent value depends heavily on claim scope and alternative implementations. |
| 4. Would infringement be detectable? | Enforcement becomes difficult when the relevant activity occurs invisibly inside a competitor's systems. |
| 5. What business objective does the patent support? | Enforcement, licensing, fundraising, deterrence, partnership, acquisition, or another strategic purpose. |
Patent strategy should follow business strategy
The point is not that companies should stop patenting technology. The point is that companies should stop treating patenting as an automatic consequence of invention.
A patent is a tool. Sometimes the tool is used for enforcement. Sometimes licensing. Sometimes investor signaling. Sometimes competitor deterrence. Sometimes acquisition strategy. Sometimes partnership leverage. Sometimes protecting a platform the company expects to build upon for twenty years.
And sometimes the correct intellectual-property strategy is something else entirely. A company may choose trade-secret protection, copyright, trademark protection, contractual protections, defensive publication, proprietary datasets, rapid commercialization, technical know-how, or simply continued innovation.
The sophisticated question is therefore not "did we invent something?" Nor is it "can we get a patent?" The better question is: what are we trying to protect, from whom, and why? And equally important: does obtaining a patent materially improve our position?
Because having a patent does not mean you have permission to build the technology. It does not guarantee freedom to operate. It does not automatically create a moat. And it certainly does not automatically create a successful business. What a patent can provide is something much more specific: the ability, within the boundaries of its claims and subject to the applicable law, to exclude others.
Sometimes that right is incredibly valuable. Sometimes the strategic uncertainty it creates is valuable. Sometimes the negotiating leverage it creates is valuable. Sometimes the signal it sends investors is valuable. And sometimes the money would be better spent building something else. That is why not everything needs a patent.
This is not legal advice. This article discusses patent strategy from a business and technology-commercialization perspective. Questions involving patentability, infringement, freedom to operate, or specific patent rights should be evaluated with qualified patent counsel.